UNLYD yields 3.53% · JNJ yields 2.13%● Live data
📍 JNJ pulled ahead of the other in Year 9
Combined, UNLYD + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of UNLYD + JNJ for your $10,000?
Unilever PLC operates as a fast-moving consumer goods company in the Asia Pacific, Africa, the Americas, and Europe. It operates through Beauty & Wellbeing, Personal Care, Home Care, and Foods segments. The Beauty & Wellbeing segment engages in the sale of hair care products, such as shampoo, conditioner, and styling; skin care products, including face, hand, and body moisturizers; and Prestige beauty and wellbeing products. The Personal Care segment offers skin cleansing products comprising soaps and showers; deodorants; and oral care products consisting of toothpaste, toothbrush, and mouthwash products. The Home Care segment is involved in the sale of fabric care products, including washing powders and liquids, and rinse conditioners; and fabric enhancers, and home and hygiene cleaning products. The Foods segment provides cooking aids and mini meals, such as soups, bouillons, and seasonings, as well as condiments, mayonnaise and ketchup, and food solutions. The company provides its products under the AXE, Ben & Jerry's, Clear, Cif, Closeup, Comfort, Cornetto, Dermalogica, Domestos, Dove, Dove Men+Care, Hellmann's, Horlicks, Knorr, LUX, Lifebuoy, Liquid I.V., Nutrafol, OMO, Pond's, Paula's Choice, Pepsodent, Rexona, Sunlight, Sunsilk, Surf, TRESemmé, Vaseline, Wall's, and Yasso brand names. Unilever PLC was founded in 1860 and is headquartered in London, the United Kingdom.
Full UNLYD Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.